Showing results (261-270 of 1,142) with videos related to

Sort By:
Pageof 115
Biochemical and Biophysical Research Communications|April 21, 2010
Analysis of antigen-presenting functionality of cultured rat hepatic stellate cells and transdifferentiated myofibroblastsMichael Bomble, Frank Tacke, Lothar Rink, et al.
Hepatic Oncology|July 11, 2020
Systemic treatment of hepatocellular carcinoma: from sorafenib to combination therapiesChristoph Roderburg, Burcin Özdirik, Alexander Wree, et al.
Case Reports in Gastrointestinal Medicine|June 24, 2025
Late Onset of Pseudoachalasia in Anti-Hu-Associated SyndromeJens Jaekel, Christian Jürgensen, Frank Tacke, et al.
Therapeutic Advances in Chronic Disease|July 20, 2019
Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidenceXiangbo Xu, Xiaozhong Guo, Frank Tacke, et al.
Hepatic Oncology|April 11, 2020
The role of the innate immune system in the development and treatment of hepatocellular carcinomaChristoph Roderburg, Alexander Wree, Münevver Demir, et al.
International Journal of Molecular Sciences|March 29, 2023
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor ProgressionAlena Laschtowitz, Joeri Lambrecht, Tobias Puengel, et al.
Seminars in Liver Disease|May 28, 2024
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Scientific Reports|January 12, 2017
MicroRNA-155 is upregulated in ascites in patients with spontaneous bacterial peritonitisPhilipp Lutz, Mohamed M Haimid, Alessandra Pohlmann, et al.
Hepatology Communications|May 20, 2022
Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic ratsLakmie S Gunarathne, Indu G Rajapaksha, Stephen Casey, et al.
Scientific Reports|September 9, 2017
Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individualsDaniel D Murray, Kazuo Suzuki, Matthew Law, et al.
Pageof 115